Bharat Biotech’s Covid nasal vaccine gets approval in India
New Delhi, Nov 28: Bharat Biotech’s needle-free intranasal Covid vaccine has been cleared for restricted use in emergencies for those above the age of 18 years. iNCOVACC will become the first intranasal vaccine in the world. “iNCOVACC is a recombinant
Source: India News, India Breaking News, Latest news headlines in India – Oneindia News